ArticleOncotarget2018
EpCAM
Abstract read
In one paragraph
Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
61 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Circulating Tumor Cell Detection for Therapeutic and Prognostic Roles in Breast Cancer.Cancer medicine · 2025Pooled it
- Prognostic value of circulating tumor cells detected with the CellSearch system in esophageal cancer patients: a systematic review and meta-analysis.BMC cancer · 2020Pooled it
- Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast Cancer.Scientific reports · 2020Trial
- Circulating tumour cells as a window into lethality in prostate cancer.Nature reviews. Urology · 2026Review
- Flow Enabled Target Capture Halbach-based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients.Molecular oncology · 2026Article
- Aptamer-based NIR II imaging for breast cancer surgical resection.Npj imaging · 2025Article
- Article
- Article
- Circulating tumor cellsTranslational breast cancer research : a journal focusing on translational research in breast cancer · 2024Review
- Association between EPCAM upregulation and clinicopathological parameters and outcomes of breast cancer.International journal of clinical and experimental pathology · 2024Article
- Hsp70-A Universal Biomarker for Predicting Therapeutic Failure in Human Female Cancers and a Target for CTC Isolation in Advanced Cancers.Biomedicines · 2023Article
- Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value.British journal of cancer · 2023Article
- Significance of circulating tumor cells in lung cancer: a narrative review.Translational lung cancer research · 2023Review
- Measuring antigen expression of cancer cell lines and circulating tumour cells.Scientific reports · 2023Article
- Accurate prostate cancer detection based on enrichment and characterization of prostate cancer specific circulating tumor cells.Cancer medicine · 2023Article
- MiSelect R System: the validation of a new detection system of CTCs and their correlation with prognosis in non-metastatic CRC patients.Scientific reports · 2023Article
- Electrochemical Genosensing of Overexpressed GAPDH Transcripts in Breast Cancer Exosomes.Analytical chemistry · 2023Article
- Copy Number Variations as Determinants of Colorectal Tumor Progression in Liquid Biopsies.International journal of molecular sciences · 2023Review
- Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells.Cancers · 2022Article
- A preliminary study on the association between epithelial-mesenchymal transition and circulating tumor cells in renal cell carcinoma.Translational andrology and urology · 2022Article
1 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors.
Sanne de WitDepartment of Medical Cell BioPhysics, Faculty of Sciences and Technology, MIRA Institute, University of Twente, Enschede, The Netherlands.
Mariangela ManiconeVeneto Institute of Oncology IOV-IRCCS, Padova, Italy.
Elisabetta RossiVeneto Institute of Oncology IOV-IRCCS, Padova, Italy.
Rita LampignanoDepartment of Obstetrics and Gynecology, Heinrich-Heine-University, Düsseldorf, Germany.
Liwen YangDepartment of Obstetrics and Gynecology, Heinrich-Heine-University, Düsseldorf, Germany.
Beate ZillDepartment of Gynecology and Obstetrics, Ludwig-Maximilians-University, Munich, Germany.
Alvera Rengel-PuertasDepartment of Gynecology and Obstetrics, Ludwig-Maximilians-University, Munich, Germany.
Marianne Ouhlen"Circulating Tumor Cells" Translational Platform, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Mateus CrespoCancer Biomarkers, The Institute of Cancer Research, Sutton, United Kingdom.
Anne Margreet Sofie BerghuisDepartment of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, MIRA Institute, University of Twente, Enschede, The Netherlands.
Kiki Carlijn AndreeDepartment of Medical Cell BioPhysics, Faculty of Sciences and Technology, MIRA Institute, University of Twente, Enschede, The Netherlands.
Riccardo VidottoVeneto Institute of Oncology IOV-IRCCS, Padova, Italy.
Elisabeth Katharina TrappDepartment of Gynecology and Obstetrics, Ludwig-Maximilians-University, Munich, Germany.
Marie TzschaschelDepartment of Gynecology and Obstetrics, Ulm-University, Munich, Germany.
Emeline ColombaDepartment of Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Gemma FowlerCancer Biomarkers, The Institute of Cancer Research, Sutton, United Kingdom.
Penelope FlohrCancer Biomarkers, The Institute of Cancer Research, Sutton, United Kingdom.
Pasquale RescignoCancer Biomarkers, The Institute of Cancer Research, Sutton, United Kingdom.
Mariane Sousa FontesCancer Biomarkers, The Institute of Cancer Research, Sutton, United Kingdom.
Rita ZamarchiVeneto Institute of Oncology IOV-IRCCS, Padova, Italy.
Tanja FehmDepartment of Obstetrics and Gynecology, Heinrich-Heine-University, Düsseldorf, Germany.
Hans NeubauerDepartment of Obstetrics and Gynecology, Heinrich-Heine-University, Düsseldorf, Germany.
Brigitte RackDepartment of Gynecology and Obstetrics, Ludwig-Maximilians-University, Munich, Germany.
Marianna Alunni-FabbroniDepartment of Gynecology and Obstetrics, Ludwig-Maximilians-University, Munich, Germany.
Françoise Farace"Circulating Tumor Cells" Translational Platform, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Johann De BonoCancer Biomarkers, The Institute of Cancer Research, Sutton, United Kingdom.
Maarten Joost IJzermanDepartment of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, MIRA Institute, University of Twente, Enschede, The Netherlands.
Leonardus Wendelinus Mathias Marie TerstappenDepartment of Medical Cell BioPhysics, Faculty of Sciences and Technology, MIRA Institute, University of Twente, Enschede, The Netherlands.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The presence of high expressing epithelial cell adhesion molecule (EpCAM
Indexed as
castrate-resistant prostate cancer (CRPC)circulating tumor cells (CTC)EpCAMepithelial-to-mesenchymal transition (EMT)metastatic breast cancer (mBC)
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.